Posted: Thursday, February 1, 2024
HealthLine
UPDATE Cemiplimab in Cutaneous Squamous Cell Carcinoma
Cetuximab (Non-Melanoma Skin Cancers)
Avelumab
Cemiplimab-rwlc in Cutaneous Squamous Cell Carcinoma